Corporate consolidation is reshaping veterinary care. Mars Veterinary Health, NVA, and VCA collectively operate over 5,000 practices in North America, and private equity continues to invest aggressively in roll-up strategies. For veterinary technology companies, this creates the same bifurcation dental technology is experiencing: independent practice owners who buy fast but represent shrinking market share, and corporate groups that buy slow but represent the future. If your revenue system doesn’t account for both motions, you’re optimizing for a market that’s disappearing. According to AVMA veterinary industry statistics, the market dynamics are shifting fast.
If you’re a veterinary technology company between Series A and C, your revenue problem probably isn’t what you think it is.
Revenue Patterns in Veterinary Technology and Vet Tech SaaS
Veterinary Technology has a distinct set of revenue challenges that generic sales methodologies weren’t built for. The symptoms look familiar – pipeline coverage ratios that satisfy the board but win rates that tell a different story – but the root causes are specific to how veterinary technology buyers evaluate, procure, and implement technology.
Three patterns dominate veterinary technology revenue breakdowns:
The independent-to-corporate transition. Your installed base of independent practices is being acquired by corporate groups who mandate their own technology stack. Customer retention depends on relationships with acquiring entities you may not have. Meanwhile, new independent practice openings are declining. Your growth engine is eroding from both sides – existing customers getting acquired out and new customers shrinking as a segment.
The price sensitivity wall. Independent veterinary practice owners operate on tighter margins than dentists. Your per-seat or per-location pricing that works for a five-vet hospital doesn’t work for a solo practitioner. But discounting for small practices destroys your unit economics. Without deliberate pricing architecture that serves both segments, you’re either priced out of independents or unprofitable selling to them.
The EHR integration barrier. Every veterinary practice runs on practice information management systems (PIMS) – and the market is fragmented across dozens of vendors. Your product needs to integrate with whatever PIMS the practice uses. Each integration is a development investment that your engineering team can’t afford to make for every small vendor. But without it, the deal stalls on technical incompatibility.
What a Fractional CRO Does in Veterinary Technology
A fractional Chief Revenue Officer restructures your revenue function for the consolidating veterinary market. This means building relationships and pipeline with corporate practice groups as a strategic priority, creating pricing architecture that serves both independent and enterprise segments profitably, and qualification frameworks that assess integration requirements before deals enter the pipeline rather than discovering them at implementation.
The engagement starts with a revenue diagnostic: 36-44 hours over four weeks, including stakeholder interviews across sales, marketing, and customer success. The output is a diagnostic report and action plan specific to your veterinary technology revenue challenges – not a generic playbook borrowed from another industry.
Is This Right for Your Veterinary Technology Company?
This is built for veterinary technology companies with $5M-$75M in ARR who are feeling board pressure to scale but sense that adding more pipeline isn’t the answer. You’ve probably tried a legacy sales methodology. It worked for a quarter, maybe two, then faded. The problem isn’t your team’s effort – it’s the operating system they’re executing within.
This probably isn’t right if you’re pre-product-market-fit, if you need someone to run demos and make calls, or if you’re looking for a training program rather than a revenue operating system.
If any of this maps to what you’re seeing, I’m curious which pattern resonates most. And if my read is wrong, I’d rather know where.
Related: fractional CRO for dental technology | fractional CRO for healthtech | fractional CRO in Denver
Stop the bleeding. Start a conversation – no deck, no demo.
I help B2B companies fix the revenue systems that legacy methodologies broke. If something in this post made you uncomfortable, it was probably the part that's true. Stop the bleeding.